CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL)

Historical Holders from Q1 2014 to Q4 2025

Symbol
CRL on NYSE
Type / Class
Equity / Common Stock, $0.01 par value per share
Shares outstanding
50,495,188
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
50,368,249
Holdings value
$7,916,035,129
% of all portfolios
0%
Number of holders
542
Number of buys
279
Number of sells
243
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 6.9% $352,263,880 3,524,401 BlackRock, Inc. 31 Mar 2025
WELLINGTON MANAGEMENT GROUP LLP 6.5% -24% $499,180,467 -$171,252,511 3,190,467 -26% Wellington Management Group LLP 30 Sep 2025
NOMURA HOLDINGS INC 1.6% -76% $126,407,633 -$293,166,299 807,923 -70% NOMURA HOLDINGS INC 30 Sep 2025
As of 30 Sep 2025 CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) has 542 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 50,368,249 shares of 50,495,188 outstanding shares and own 100% of the company stock as of 30 Sep 2025.

Top 25 institutional shareholders of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) own 70% of the company based on 13F filings as of 30 Sep 2025

Filer Ownership Holdings Value Nb Shares Share Change %
VANGUARD GROUP INC 12% $913,686,190 5,839,743 +0.48%
BlackRock, Inc. 7.6% $603,320,130 3,856,066 +5.5%
WELLINGTON MANAGEMENT GROUP LLP 6.3% $499,180,467 3,190,467 -15%
Allspring Global Investments Holdings, LLC 4.3% $371,295,382 2,177,941 -4.9%
STATE STREET CORP 3.6% $286,502,198 1,831,153 -1.5%
ARIEL INVESTMENTS, LLC 3% $233,140,733 1,490,098 +5.3%
HARRIS ASSOCIATES L P 2.9% $230,478,723 1,473,084 +27%
GEODE CAPITAL MANAGEMENT, LLC 2.5% $197,820,907 1,266,746 +2.8%
Invesco Ltd. 2.5% $195,446,390 1,249,178 +0.97%
BANK OF AMERICA CORP /DE/ 2.3% $182,017,429 1,163,348 +13%
DIMENSIONAL FUND ADVISORS LP 2.2% $176,909,024 1,130,905 +12%
EARNEST PARTNERS LLC 2% $157,512,037 1,006,724 +0.85%
MACKENZIE FINANCIAL CORP 2% $155,738,250 995,387 -0.66%
D. E. Shaw & Co., Inc. 1.9% $150,129,159 959,537 +58%
NATIONAL BANK OF CANADA /FI/ 1.9% $148,131,439 946,769 +118%
NEUBERGER BERMAN GROUP LLC 1.7% $132,838,110 849,512 +22%
MORGAN STANLEY 1.7% $130,611,527 834,789 +11%
NOMURA HOLDINGS INC 1.6% $126,149,787 806,275 -49%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 1.5% $120,386,113 769,437 +33%
SEI INVESTMENTS CO 1.5% $117,303,302 749,723 +4.9%
AMERIPRISE FINANCIAL INC 1.2% $96,004,558 613,604 +1491%
COOKE & BIELER LP 1.2% $94,482,595 603,877 +0.85%
UBS Group AG 1.2% $92,742,604 592,756 -19%
Van Berkom & Associates Inc. 0.98% $77,747,000 496,911 +2%
NORTHERN TRUST CORP 0.94% $74,547,557 476,464 -0.15%

Institutional Holders of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 113,680 $22,676,556 +$2,212,813 $199.48 6
2025 Q3 50,368,249 $7,916,035,129 -$80,663,537 $156.46 542
2025 Q2 50,888,032 $7,728,322,181 -$310,858,841 $151.73 512
2025 Q1 52,966,754 $7,964,797,275 -$132,268,915 $150.52 554
2024 Q4 52,958,336 $9,771,240,814 +$238,492,914 $184.60 625
2024 Q3 51,463,979 $10,132,611,038 -$16,123,570 $196.97 622
2024 Q2 52,362,977 $10,815,813,038 +$46,397,687 $206.58 652
2024 Q1 51,670,245 $13,990,897,577 -$13,168,582 $270.95 662
2023 Q4 557,393 $131,793,144 -$3,153,254 $236.40 6
2023 Q3 50,362,186 $9,861,051,576 +$146,622,847 $195.98 603
2023 Q2 50,592,360 $10,630,468,098 -$29,722,158 $210.25 597
2023 Q1 50,360,102 $10,157,640,692 +$259,182,756 $201.82 601
2022 Q4 49,422,526 $10,771,105,865 -$104,300,166 $217.90 606
2022 Q3 44,639,604 $8,785,487,237 +$296,115,460 $196.80 554
2022 Q2 48,253,064 $10,313,398,424 +$408,333,873 $213.97 602
2022 Q1 47,396,133 $13,461,277,945 +$106,448,088 $283.97 620
2021 Q4 46,676,062 $17,578,257,943 +$195,872,906 $376.78 689
2021 Q3 46,742,155 $19,295,906,199 -$271,199,969 $412.67 665
2021 Q2 46,646,734 $17,259,733,552 +$132,941,981 $369.92 622
2021 Q1 46,732,133 $13,542,344,570 +$146,733,698 $289.83 551
2020 Q4 46,793,839 $11,690,982,093 +$73,066,092 $249.86 530
2020 Q3 46,166,900 $10,451,977,239 +$23,066,230 $226.45 482
2020 Q2 43,541,484 $7,516,781,446 -$106,430,403 $174.35 449
2020 Q1 46,185,146 $5,829,798,759 -$75,123,143 $126.21 399
2019 Q4 46,934,559 $7,169,808,295 +$24,301,947 $152.76 399
2019 Q3 46,444,969 $6,148,068,684 +$102,643,125 $132.37 388
2019 Q2 46,137,396 $6,545,953,744 +$153,360,263 $141.90 395
2019 Q1 46,191,578 $6,701,193,999 +$95,918,752 $145.25 400
2018 Q4 45,415,902 $5,143,476,593 -$150,568,574 $113.18 399
2018 Q3 46,271,989 $6,221,343,273 +$100,952,576 $134.54 362
2018 Q2 46,281,452 $5,193,010,275 -$31,330,060 $112.26 342
2018 Q1 47,176,981 $5,030,210,112 +$1,903,270 $106.74 328
2017 Q4 47,214,786 $5,160,506,682 +$107,866,957 $109.45 335
2017 Q3 45,896,343 $4,957,873,742 -$9,166,437 $108.02 331
2017 Q2 45,798,408 $4,632,165,313 -$88,200,238 $101.15 295
2017 Q1 46,673,768 $4,198,144,211 +$352,415,214 $89.95 293
2016 Q4 45,790,617 $3,489,067,018 -$19,852,705 $76.19 291
2016 Q3 45,666,079 $3,802,699,494 +$8,782,336 $83.34 275
2016 Q2 45,921,010 $3,787,486,076 -$25,580,795 $82.44 275
2016 Q1 46,802,003 $3,556,189,897 +$139,405,688 $75.94 258
2015 Q4 44,933,531 $3,612,009,201 -$42,220,929 $80.39 260
2015 Q3 46,039,544 $2,924,302,828 -$39,114,866 $63.52 253
2015 Q2 46,262,229 $3,254,197,734 -$16,357,001 $70.34 259
2015 Q1 46,717,709 $3,702,050,590 +$55,775,344 $79.29 256
2014 Q4 46,271,208 $2,946,620,531 +$20,379,594 $63.64 251
2014 Q3 46,698,782 $2,789,816,513 -$86,022,545 $59.74 254
2014 Q2 47,386,312 $2,536,114,262 -$9,677,120 $53.52 258
2014 Q1 47,568,503 $2,868,958,114 +$86,326,094 $60.34 256